These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1355725)

  • 1. Carbonyl (phenone) reductase in human liver: structure-activity relationship among substrates.
    Wong JM; Mahon WA; Kalow W; Inaba T
    Drug Metab Dispos; 1992; 20(3):465-6. PubMed ID: 1355725
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of haloperidol reduction by non-steroidal anti-inflammatory drugs in human liver cytosol.
    Fayz S; Inaba T
    Drug Metabol Drug Interact; 1997; 13(3):215-30. PubMed ID: 21568812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-affinity stereoselective reduction of the enantiomers of ketotifen and of ketonic nortriptyline metabolites by aldo-keto reductases from human liver.
    Breyer-Pfaff U; Nill K
    Biochem Pharmacol; 2000 Feb; 59(3):249-60. PubMed ID: 10609553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol reductase in human and guinea pig livers.
    Inaba T; Kovacs J
    Drug Metab Dispos; 1989; 17(3):330-3. PubMed ID: 2568916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonyl (phenone) reductase in human liver: inter-individual variability.
    Wong JM; Kalow W; Kadar D; Takamatsu Y; Inaba T
    Pharmacogenetics; 1993 Apr; 3(2):110-5. PubMed ID: 8518835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic reduction of acetophenone derivatives with a benzil reductase from Pichia glucozyma (KRED1-Pglu): electronic and steric effects on activity and enantioselectivity.
    Contente ML; Serra I; Palazzolo L; Parravicini C; Gianazza E; Eberini I; Pinto A; Guidi B; Molinari F; Romano D
    Org Biomol Chem; 2016 Apr; 14(13):3404-8. PubMed ID: 26952764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver.
    Ohara H; Miyabe Y; Deyashiki Y; Matsuura K; Hara A
    Biochem Pharmacol; 1995 Jul; 50(2):221-7. PubMed ID: 7632166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical modification of histidine residue in substrate-binding domain of carbonyl reductase from rabbit kidney.
    Imamura Y; Higuchi T; Otagiri M
    Biochem Mol Biol Int; 1993 Dec; 31(6):1105-10. PubMed ID: 8193594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde reductases: enzymes in search of a function.
    Turner AJ
    Prog Clin Biol Res; 1982; 114():183-95. PubMed ID: 6761706
    [No Abstract]   [Full Text] [Related]  

  • 10. Conversion of bromperidol to reduced bromperidol in human liver.
    Someya T; Inaba T; Tyndale RF; Tang SW; Takahashi S
    Neuropsychopharmacology; 1991 Nov; 5(3):177-82. PubMed ID: 1755933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverting the enantioselectivity of a carbonyl reductase via substrate-enzyme docking-guided point mutation.
    Zhu D; Yang Y; Majkowicz S; Pan TH; Kantardjieff K; Hua L
    Org Lett; 2008 Feb; 10(4):525-8. PubMed ID: 18205368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic conversion of prostaglandin H2 to prostaglandin F2 alpha by aldehyde reductase from human liver.
    Hayashi H; Fujii Y; Watanabe K; Urade Y; Hayaishi O
    Prog Clin Biol Res; 1989; 290():365-79. PubMed ID: 2657759
    [No Abstract]   [Full Text] [Related]  

  • 13. Haloperidol metabolism in psychiatric patients: importance of glucuronidation and carbonyl reduction.
    Someya T; Shibasaki M; Noguchi T; Takahashi S; Inaba T
    J Clin Psychopharmacol; 1992 Jun; 12(3):169-74. PubMed ID: 1629382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pathway of ethanol metabolism in the liver.
    Lieber CS
    Gastroenterology; 1970 Dec; 59(6):930-7. PubMed ID: 4395020
    [No Abstract]   [Full Text] [Related]  

  • 15. Carbonyl reduction of timiperone in human liver cytosol.
    Shimoda K; Shibasaki M; Inaba T; Cheung SW; Someya T; Takahashi S
    Pharmacol Toxicol; 1998 Oct; 83(4):164-8. PubMed ID: 9820877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonyl reductase activity for acetohexamide in human erythrocytes.
    Kishimoto M; Kawamori R; Kamada T; Inaba T
    Drug Metab Dispos; 1994; 22(3):367-70. PubMed ID: 8070312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interindividual variability of carbonyl reductase levels in human livers.
    Iwata N; Inazu N; Hara S; Yanase T; Kano S; Endo T; Kuriiwa F; Sato Y; Satoh T
    Biochem Pharmacol; 1993 Apr; 45(8):1711-4. PubMed ID: 8484808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A photocatalyst/enzyme couple that uses solar energy in the asymmetric reduction of acetophenones.
    Choudhury S; Baeg JO; Park NJ; Yadav RK
    Angew Chem Int Ed Engl; 2012 Nov; 51(46):11624-8. PubMed ID: 23065709
    [No Abstract]   [Full Text] [Related]  

  • 19. Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue.
    Shafqat N; Shafqat J; Eissner G; Marschall HU; Tryggvason K; Eriksson U; Gabrielli F; Lardy H; Jörnvall H; Oppermann U
    Cell Mol Life Sci; 2006 May; 63(10):1205-13. PubMed ID: 16685466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereospecific reduction of haloperidol in human tissues.
    Eyles DW; Pond SM
    Biochem Pharmacol; 1992 Sep; 44(5):867-71. PubMed ID: 1530656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.